Semi-Annual Consolidated Statement Of Income

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7271855

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Semi-annual consolidated statement of income
Statement of income
Net sales	—	—	—	1,166,276,000,000 JPY	—	1,105,883,000,000 JPY	—	—
Cost of sales	—	—	—	332,855,000,000 JPY	—	406,600,000,000 JPY	—	—
Ordinary profit (loss)	—	—	—	542,500,000,000 JPY	—	442,014,000,000 JPY	—	—
Gross profit (loss)	—	—	—	833,422,000,000 JPY	—	699,283,000,000 JPY	—	—
Selling, general and administrative expenses
Selling, general and administrative expenses	—	—	—	298,998,000,000 JPY	—	278,107,000,000 JPY	—	—
Extraordinary income	—	—	—	5,000,000 JPY	—	14,125,000,000 JPY	—	—
Extraordinary losses	—	—	—	1,001,000,000 JPY	—	13,176,000,000 JPY	—	—
Profit (loss) before income taxes	—	—	—	541,504,000,000 JPY	—	442,962,000,000 JPY	—	—
Operating profit (loss)	—	—	—	534,424,000,000 JPY	—	421,176,000,000 JPY	—	—
Non-operating income
Non-operating income	—	—	—	13,969,000,000 JPY	—	23,008,000,000 JPY	—	—
Income taxes - current	—	—	—	167,358,000,000 JPY	—	115,924,000,000 JPY	—	—
Income taxes - deferred	—	—	—	-12,397,000,000 JPY	—	2,334,000,000 JPY	—	—
Non-operating expenses
Interest expenses	—	—	—	0 JPY	—	213,000,000 JPY	—	—
Non-operating expenses	—	—	—	5,893,000,000 JPY	—	2,171,000,000 JPY	—	—
Income taxes	—	—	—	154,961,000,000 JPY	—	118,258,000,000 JPY	—	—
Profit (loss)	386,543,000,000 JPY	386,543,000,000 JPY	386,543,000,000 JPY	386,543,000,000 JPY	324,704,000,000 JPY	324,704,000,000 JPY	324,704,000,000 JPY	324,704,000,000 JPY
Extraordinary income
Gain on sale of non-current assets	—	—	—	5,000,000 JPY	—	13,990,000,000 JPY	—	—
Extraordinary losses
Loss on sale of non-current assets	—	—	—	7,000,000 JPY	—	268,000,000 JPY	—	—